Can azathioprine cause chronic interstitial nephritis?

Azathioprine Can Cause Acute Interstitial Nephritis, Not Chronic Interstitial Nephritis

Azathioprine causes acute interstitial nephritis (AIN) as a hypersensitivity reaction, typically occurring within 2-3 weeks of drug initiation, but there is no established evidence that it causes chronic interstitial nephritis. The distinction is critical: AIN is a reversible, immune-mediated drug reaction, while chronic interstitial nephritis implies long-term, progressive kidney damage that azathioprine does not directly cause.

The Evidence for Acute Interstitial Nephritis

The FDA drug label does not list interstitial nephritis among azathioprine's adverse effects 1, but multiple case reports document acute interstitial nephritis as a rare hypersensitivity reaction:

• Timing is characteristic: AIN develops within 2-3 weeks of starting azathioprine 2, 3, 4
• Clinical presentation: Fever, worsening renal function, elevated inflammatory markers, and eosinophilia 3, 4
• Histology: Biopsy shows acute tubulointerstitial nephritis with eosinophilic infiltrate 2, 3
• Rechallenge confirms diagnosis: Symptoms recur within days when azathioprine is restarted 4

Key Clinical Pitfall: Don't Assume Disease Relapse

In patients with autoimmune diseases (especially ANCA-associated vasculitis) on azathioprine who develop worsening renal function, the immediate assumption should not be disease relapse 3. The case of ANCA MPO vasculitis demonstrates this perfectly: worsening kidney function 2 weeks after starting azathioprine was initially suspected to be vasculitis relapse, but biopsy revealed drug-induced AIN 3.

Look for these distinguishing features:

• Timing: Within 2-3 weeks of drug initiation
• Systemic symptoms: Fever, malaise, rash
• Urine sediment: White blood cells, eosinophiluria (not the active sediment of glomerulonephritis) 2
• Inflammatory markers: Elevated despite immunosuppression

Management Algorithm

1. Immediately discontinue azathioprine when AIN is suspected
2. Obtain kidney biopsy if diagnosis is uncertain or if distinguishing from disease relapse is critical 2, 3
3. Expect recovery: Most patients show sustained improvement in renal function after drug cessation 3
4. Do not rechallenge: Symptoms recur rapidly and can be more severe 4
5. Switch to alternative immunosuppression: Consider mycophenolate mofetil or other agents

Chronic Interstitial Nephritis: No Direct Evidence

There is no evidence that azathioprine causes chronic interstitial nephritis through direct toxicity. The British Association of Dermatologists guidelines recommend dose reduction in patients with pre-existing renal impairment 5, but this is a precautionary measure for drug clearance, not because azathioprine causes progressive kidney damage.

The only scenario where "chronic" kidney damage might occur is if acute interstitial nephritis goes unrecognized and the drug is continued, potentially leading to irreversible fibrosis. However, this represents untreated acute injury progressing to chronicity, not a primary chronic process.

Dosing Considerations in Renal Impairment

The FDA label and guidelines recommend lower doses in patients with existing renal impairment 5, 1, but this reflects altered drug metabolism and increased toxicity risk, not nephrotoxicity per se. The primary concern is bone marrow suppression, not kidney damage.